Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mylin A Torres

Showing results (1-10 of 83) with videos related to

Pageof 9
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 17, 2019
Implications of ARTIC: Is This the Beginning of a Climate Change?Mylin A Torres
International Journal of Radiation Oncology, Biology, Physics|March 23, 2019
Genomic Assays to Assess Local Recurrence Risk and Predict Radiation Therapy Benefit in Patients With Ductal Carcinoma In SituMylin A Torres
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 5, 2023
POLARized Risk for Local Recurrence on the Basis of Tumor Biology: Is It That Simple?Mylin A Torres
International Journal of Radiation Oncology, Biology, Physics|May 13, 2023
Asian American and Pacific Islander Female Faculty and the Double WhammyMylin A Torres
JAMA|March 11, 2020
Radiation Oncology Alternative Payment Model-ReplyDavid H Howard, Mylin A Torres
JAMA|October 10, 2019
Alternative Payment for Radiation OncologyDavid H Howard, Mylin A Torres
Journal of the National Cancer Institute|October 25, 2019
Intensity-Modulated Radiation Therapy in Breast Cancer Patients Following the Release of a Choosing Wisely RecommendationMylin A Torres, Keerthi Gogineni, David H Howard
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 23, 2020
Postmastectomy and Regional Nodal Radiation for Breast CancerMylin A Torres, Kathleen C Horst, Gary M Freedman
The Breast Journal|August 27, 2019
Time from Completion of Neo-adjuvant Chemotherapy to Surgery: Effects on Outcomes in Breast Cancer PatientsCletus Arciero, Karen Buhariwalla, Yuan Liu, et al.
Investigational New Drugs|February 2, 2010
AC480, formerly BMS-599626, a pan Her inhibitor, enhances radiosensitivity and radioresponse of head and neck squamous cell carcinoma cells in vitro and in vivoMylin A Torres, Uma Raju, David Molkentine, et al.
Pageof 9

Showing results (1-10 of 83) with videos related to

Sort By:
Pageof 9
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 17, 2019
Implications of ARTIC: Is This the Beginning of a Climate Change?Mylin A Torres
International Journal of Radiation Oncology, Biology, Physics|March 23, 2019
Genomic Assays to Assess Local Recurrence Risk and Predict Radiation Therapy Benefit in Patients With Ductal Carcinoma In SituMylin A Torres
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 5, 2023
POLARized Risk for Local Recurrence on the Basis of Tumor Biology: Is It That Simple?Mylin A Torres
International Journal of Radiation Oncology, Biology, Physics|May 13, 2023
Asian American and Pacific Islander Female Faculty and the Double WhammyMylin A Torres
JAMA|March 11, 2020
Radiation Oncology Alternative Payment Model-ReplyDavid H Howard, Mylin A Torres
JAMA|October 10, 2019
Alternative Payment for Radiation OncologyDavid H Howard, Mylin A Torres
Journal of the National Cancer Institute|October 25, 2019
Intensity-Modulated Radiation Therapy in Breast Cancer Patients Following the Release of a Choosing Wisely RecommendationMylin A Torres, Keerthi Gogineni, David H Howard
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 23, 2020
Postmastectomy and Regional Nodal Radiation for Breast CancerMylin A Torres, Kathleen C Horst, Gary M Freedman
The Breast Journal|August 27, 2019
Time from Completion of Neo-adjuvant Chemotherapy to Surgery: Effects on Outcomes in Breast Cancer PatientsCletus Arciero, Karen Buhariwalla, Yuan Liu, et al.
Investigational New Drugs|February 2, 2010
AC480, formerly BMS-599626, a pan Her inhibitor, enhances radiosensitivity and radioresponse of head and neck squamous cell carcinoma cells in vitro and in vivoMylin A Torres, Uma Raju, David Molkentine, et al.
Pageof 9